Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic stem cell transplantation

S Jagannath1, B Barlogie, G Tricot

  • 1University of Arkansas.

Hospital Practice (Office Ed.)
|August 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Leukemia·2018
Same author

Drug response prediction in high-risk multiple myeloma.

Gene·2017
Same author

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nature communications·2017
Same author

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Leukemia·2017
Same author

NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma.

Leukemia·2017
Same author

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Blood cancer journal·2017
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

Hematopoietic stem cell expansion enables pretransplant manipulation for rapid blood cell reconstitution. This method minimizes graft-versus-host disease in patients undergoing high-dose chemotherapy.

Area of Science:

  • Hematology
  • Immunology
  • Cell Biology

Background:

  • Hematopoietic stem cells (HSCs) are crucial for blood formation and immune system reconstitution.
  • Advances in cell culture techniques allow for the manipulation of HSCs ex vivo.
  • High-dose chemotherapy necessitates effective strategies for restoring hematologic function and preventing immune complications.

Purpose of the Study:

  • To describe the process of isolating, purifying, and expanding hematopoietic stem cells in vitro.
  • To highlight the potential of these manipulated HSCs in clinical applications.
  • To demonstrate the feasibility of achieving rapid hematologic reconstitution with reduced graft-versus-host disease.

Main Methods:

  • Isolation and purification of hematopoietic stem cells from a source (e.g., peripheral blood, bone marrow).

Related Experiment Videos

  • In vitro expansion of purified HSCs using specific culture media and growth factors.
  • Assessment of HSC function and viability post-expansion.

    • Main Results:

    • Successful isolation, purification, and expansion of functional hematopoietic stem cells were achieved.
    • Pretransplant immunologic and genetic manipulation of HSCs became feasible.
    • Demonstrated potential for rapid allogeneic or autologous hematologic reconstitution.

    Conclusions:

    • In vitro expansion of hematopoietic stem cells is a viable strategy for clinical applications.
    • This approach allows for targeted pretransplant manipulation, enhancing therapeutic outcomes.
    • The method holds promise for minimizing graft-versus-host disease in patients receiving high-dose chemotherapy.